Second Department of Orthopaedics, The Third Affiliated Hospital of Qiqihar Medial University, Qiqihar, 161000, China.
Wuzhou Red Cross Hospital, Wuzhou, 543002, China.
J Orthop Surg Res. 2023 Nov 8;18(1):848. doi: 10.1186/s13018-023-04330-2.
Osteosarcoma (OS) is a refractory malignancy. This study aimed to explore the roles and mechanisms of Inhibin subunit beta A (INHBA) in OS.
INHBA expression levels in OS tissues and cells were assessed using RT-qPCR and western blotting. The impact of INHBA silencing on OS development was then explored by transfecting the OS cell lines U2OS and MG63 with INHBA-small interfering RNA (siRNA). The influence of INHBA silencing on U2OS and MG63 cell proliferation, migration, and invasion was examined using MTT and Transwell assays. Epithelial-mesenchymal transition (EMT) markers (E-cadherin and N-cadherin) were analyzed by RT-qPCR. The expression of genes involved in cell proliferation, migration, invasion, and the TGF-β signaling pathway was evaluated by western blotting and RT-qPCR.
INHBA levels were elevated in the OS tissues and cells. Furthermore, the transforming growth factor-β (TGF-β) signaling pathway of OS cells was suppressed in response to INHBA-siRNA, whereas proliferation, migration, and invasion of OS cells were inhibited. Besides, INHBA-siRNA significantly inhibited OS cell EMT, evidenced by enhanced E-cadherin mRNA expression and reduced N-cadherin mRNA expression. Further mechanistic studies revealed that the TGF-β1 agonist SRI-011381 hydrochloride increased OS cell proliferation, migration, and invasion after INHBA downregulation.
We found that INHBA silencing could play a vital role in OS via TGF-β1-regulated proliferation, migration, and invasion.
骨肉瘤(OS)是一种难治性恶性肿瘤。本研究旨在探讨抑制素亚基β A(INHBA)在 OS 中的作用和机制。
采用 RT-qPCR 和 Western blot 检测 OS 组织和细胞中 INHBA 的表达水平。然后,通过转染 OS 细胞系 U2OS 和 MG63 的 INHBA 小干扰 RNA(siRNA),探讨 INHBA 沉默对 OS 发展的影响。通过 MTT 和 Transwell 测定,研究 INHBA 沉默对 U2OS 和 MG63 细胞增殖、迁移和侵袭的影响。采用 RT-qPCR 分析上皮-间充质转化(EMT)标志物(E-钙粘蛋白和 N-钙粘蛋白)。通过 Western blot 和 RT-qPCR 评估与细胞增殖、迁移、侵袭和 TGF-β 信号通路相关的基因表达。
INHBA 在 OS 组织和细胞中表达上调。此外,INHBA-siRNA 抑制 OS 细胞的转化生长因子-β(TGF-β)信号通路,同时抑制 OS 细胞的增殖、迁移和侵袭。此外,INHBA-siRNA 显著抑制 OS 细胞 EMT,表现为 E-钙粘蛋白 mRNA 表达增强和 N-钙粘蛋白 mRNA 表达降低。进一步的机制研究表明,TGF-β1 激动剂 SRI-011381 盐酸盐在 INHBA 下调后可增加 OS 细胞的增殖、迁移和侵袭。
我们发现 INHBA 沉默可通过 TGF-β1 调节的增殖、迁移和侵袭在 OS 中发挥重要作用。